A 7-year-old is referred for failing school performance. His teacher reports he is unable to sit still, frequently interrupts, and loses things. He has symptoms in both school and home settings, present for more than 6 months since before age 12. DSM-5 diagnosis of ADHD combined presentation is suspected. Which medication and dosing principle is CORRECT for his initial pharmacotherapy?
- A Atomoxetine; start at full dose as it is a non-stimulant and safer
- B Methylphenidate; start low (0.3 mg/kg/dose), titrate weekly based on response and tolerability ✓
- C Amphetamine salts as first-line in India per NDPS Act regulations
- D Clonidine; preferred as it has dual benefit for sleep disorders in ADHD
Explanation
Per AAP and IAP ADHD guidelines, stimulant medications (methylphenidate or amphetamines) are first-line pharmacotherapy for ADHD in school-age children (6+ years). Methylphenidate is initiated at a low dose (~0.3 mg/kg/dose BID) and titrated upward by 5 mg every 1–2 weeks based on efficacy and side effects, up to a maximum of ~1–1.2 mg/kg/dose. In India, amphetamine salts (Adderall) are not freely available due to NDPS Act controls, making methylphenidate the standard first-line stimulant. Atomoxetine (a non-stimulant, selective norepinephrine reuptake inhibitor) is an alternative but is not started at full dose — it is titrated from 0.5 mg/kg/day to 1.2 mg/kg/day. Clonidine is used as an adjunct or for ADHD with comorbid tics/sleep issues, not as primary monotherapy.
Reference: Ghai Essential Pediatrics, 10th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.